EUVIMEDEUVIMED entdecken
Crossref

Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment

Nancy H C Loos, Viët Bui, Daniëlle H de Jong, Maria C Lebre, Hilde Rosing, Jos H Beijnen, Alfred H Schinkel

Cancer Chemotherapy and Pharmacology · 2024

DOI: 10.1007/s00280-024-04662-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2024. Verfasst von Nancy H C Loos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. Hauptthemen laut MEDLINE: Ritonavir, Docetaxel, Loperamide, Cytochrome P-450 CYP3A. Die Arbeit nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RitonavirDocetaxelLoperamideCytochrome P-450 CYP3ATaxoidsDrug InteractionsAnimalsMiceAdministration, OralHumansTissue DistributionAntineoplastic AgentsCytochrome P-450 CYP3A InhibitorsArea Under CurveAntidiarrhealsMice, Transgenic

Stichwörter der Autor:innen

Cytochrome P450 3A (CYP3A4)DocetaxelLoperamideOral taxanesPharmacokineticsRitonavir

Substanzen

RitonavirDocetaxelLoperamideCytochrome P-450 CYP3ATaxoidsAntineoplastic AgentsCytochrome P-450 CYP3A InhibitorsAntidiarrheals

Autor:innen und Institutionen

  • Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
  • Division of Pharmacy and Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.
  • Division of Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. a.schinkel@nki.nl.

Zitieren

APA

Loos, N. H. C., Bui, V., de Jong, D. H., Lebre, M. C., Rosing, H., Beijnen, J. H., & Schinkel, A. H. (2024). Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04662-8

Vancouver

Loos NHC, Bui V, de Jong DH, Lebre MC, Rosing H, Beijnen JH, et al. Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment. Cancer Chemotherapy and Pharmacology. 2024. doi:10.1007/s00280-024-04662-8

BibTeX
@article{Loos2024,
  author = {Loos, Nancy H C and Bui, Viët and de Jong, Daniëlle H and Lebre, Maria C and Rosing, Hilde and Beijnen, Jos H and Schinkel, Alfred H},
  title = {Impact of loperamide on the pharmacokinetics and tissue disposition of ritonavir-boosted oral docetaxel therapy; a preclinical assessment},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2024},
  doi = {10.1007/s00280-024-04662-8}
}
Kostenlos starten →